Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (1): 77-80.doi: 10.6040/j.issn.1671-7554.0.2019.1313

Previous Articles    

Efficacy of high flow nasal cannulae therapy for acute cardiogenic pulmonary edema

ZHANG Guoying1, WANG Jing1, WANG Chuanxia2, ZHANG Xuan3, CHI Xiangyu1, LI Qing1   

  1. 1. Department of Geriatric Respiratory Disease, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Department of Geriatric Disease, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    3. Postdoctoral Mobile Station of Shandong University of Traditional Chinese Medicine, Jinan 250000, Shandong, China
  • Published:2022-09-27

PDF (PC)

12

Abstract: Objective To explore the clinical efficacy of high flow nasal cannulae(HFNC)therapy for patients with cardiogenic pulmonary edema. Methods A total of 14 patients with cardiogenic pulmonary edema treated with HFNC therapy during ist Oct. 2018 and ist Aug. 2019 were selected as the treatment group, and another 12 patients with cardiogenic pulmonary edema who received routine oxygen therapy during the same period served as the control group. The respiratory rate, blood oxygen saturation, comfort and other indicators of the two groups were compared. Results All patients in the treatment group achieved effective clinical control, pulmonary edema was effectively treated, symptoms and signs were improved, and oxygenation indexes were increased (P=0.048). Compared with control group, treatment group had lower 0.5 h, 1 h and 12 h respiratory rate; lower 0.5 h, 1 h, 6 h, 12 h and 24 h heart rate; and lower 1 h mMRC. Conclusion HFNC therapy is effective in the treatment of cardiogenic pulmonary edema.

Key words: High flow nasal cannulae therapy, Cardiogenic pulmonary edema, Clinical efficacy

CLC Number: 

  • R563
[1] Schmickl CN, Pannu S, Al-Qadi MO, et al. Decision support tool for differential diagnosis of Acute respiratory Distress Syndrome(ARDS)vs Cardiogenic Pulmonary Edema(CPE): a prospective validation and meta-analysis [J]. Crit Care, 2014, 18(6): 659-667.
[2] Pagano A, Numis FG, Rosato V, et al. Pressure support ventilation vs Continuous positive airway pressure for treating of acute cardiogenic pulmonary edema:a pilot study [J]. Respir Physiol Neurobiol, 2018, 255(4): 7-10.
[3] Lee JH, Rehder KJ, Williford L, et al. Use of high flow nasal cannula in critically ill infants,children,and adults: a critical review of the literature [J]. Intensive Care Med, 2013, 39(2): 247-257.
[4] Nishimura M. High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects [J]. Respir Care, 2016, 61(4): 529-541.
[5] Sitthikarnkha P, Samransamruajkit R, Prapphal N, et al. High flow nasal cannula versus conventional oxygen therapy in children with respiratory distress [J]. Indian J Crit Care Med, 2018, 22(5): 321-325.
[6] 许迎辉, 李响, 李哲勇, 等. 经鼻高流量湿化氧疗在急性呼吸衰竭中的应用效果[J]. 中国当代医药, 2018, 25(24): 75-77. XU Yinghui, LI Xiang, LI Zheyong, et al. Application effect of nasal high flow humidified oxygen therapy in acute respiratory failure [J]. China Modern Medicine, 2018, 25(24): 75-77.
[7] 沈悦好, 刘素彦. 经鼻高流量湿化氧疗在呼吸系统疾病中的研究进展[J]. 中国医学创新, 2017, 14(36): 145-148. SHEN Yuehao, LIU Suyan. Research progress of transnasal high flow humidification oxygen therapy in respiratory diseases [J]. Medical Innovation of China, 2017, 14(36): 145-148.
[8] 王晓丹, 张玉想. 经鼻高流量湿化氧疗在急性呼吸衰竭中的作用研究进展[J]. 国际呼吸杂志, 2017, 37(6): 477-480. WANG Xiaodan, ZHANG Yuxiang. Research advances in the role of HFNC in acute respiratory failure [J]. International Journal of Respiration, 2017, 37(6): 477-480.
[9] 解立新, 詹庆元. 成人经鼻高流量湿化氧疗临床规范应用专家共识[J]. 中华结核和呼吸杂志, 2019, 42(2): 83-91. XIE Lixin, ZHAN Qingyuan. Expert consensus of high-flow nasal cannula oxygen therapy on clinical application regularity [J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(2): 83-91.
[10] Spoletini G, Alotaibi M, Blasi F, et al. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications [J]. Chest, 2015, 148(1): 253-261.
[11] Frat JP, Thme Aw, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemjc respiratory failure [J]. N Engl J Med, 2015, 372(23): 2185-2196.
[12] Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device [J].Eur Respir Rev, 2017, 26(145). pii:170028. doi: 10.1183/16000617. 0028-2017.
[13] Sztrymf B, Messika J, Mayot T, et al. Impact of high-flow nasal cannula oxygen therapy on intensive care unit participants with acute respiratory failure: a prospective observational study [J]. J Crit Care, 2012, 27(3): 324.e9-13. doi: 10.1016/j.jcrc.2011.07.075.
[14] Schwabbauer N, Berg B, Blumenstock G, et al. Nasal high-flow oxygen therapy in participants with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation(NIV)[J]. BMC Anesthesiol, 2014, 14: 66. doi: 10.1186/1471-2253-14-66.
[15] 王建军, 姜宏英, 李勍. 经鼻高流量湿化氧疗与无创正压通气治疗慢性阻塞性肺疾病急性加重伴Ⅱ型呼吸衰竭的随机对照研究[J]. 中国急救医学, 2019, 39(10): 945-948.
[16] 伯梦云, 万秋, 唐莉歆. 经鼻高流量湿化氧疗与无创正压通气对慢阻肺高碳酸血症的治疗效果对比分析[J]. 医药前沿, 2019, 9(24): 467-68.
[17] Carratalft Perales Jm, Llorens P, Brouzet B, et al. High-flow therapy via nasal cannula in acute heart failure [J]. Rev Esp Cardiol, 2011, 64(8): 723-725.
[18] 胡志青, 叶正龙. 经鼻高流量湿化氧疗在急性心力衰竭的临床研究进展[J]. 中国临床研究, 2019, 32(4): 564-565.
[19] Sztrymf B, Messika J, Bertrand F, et al. Beneficial effects of humidified high flow nasal oxygen in critical care participants: a prospective pilot study [J]. Intensive Care Med, 2011, 37(1): 1780-1786.
[20] Schwabbauer N, Berg B, Blumenstock G, et al. Nasal high-flow oxygen therapy in participants with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation(NIV)[J]. BMC Anesthesiol, 2014, 14: 66. doi:10.1186/1471-2253-14-66.
[21] Rittayamai N, Tscheikuna J, Praphruetkit N, et al. Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department [J]. Respir Care, 2015, 60(10): 1377-1382.
[22] Carratalá Perales JM, Llorens P, Brouzet B, et al. high-flow therapy via nasal cannula in acute heart failure [J]. Rev Esp Cardiol, 2011, 64(8): 723-725.
[23] Roca O, Pérez-Terán P, Masclans JR, et al. Participants with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy [J]. J Crit Care, 2013, 28(5): 741-746.
[1] PAN Yanyan, SUN Yongchao, LIU Xuemei, ZHANG Hongxia, ZHOU Weiran, ZHAO Cuifen. Correlation between urinary α1-antitrypsin and transferrin levels and hormone therapy effect on childrens primary nephrotic syndrome [J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 74-79.
[2] WEI Mingyong, REN Huiling, WU Jun, PENG Xue, XIE Wenfu, ZHANG Min. Clinical efficacy of endoscopic resection of small colorectal polyps with thermal biopsy forceps [J]. Journal of Shandong University (Health Sciences), 2018, 56(6): 47-50.
[3] GENG Erdong, NING Juan. Efficacy of atenolol on the treatment of acute coronary syndrome complicated with arrhythmia and the prognosis [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 70-73.
[4] PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd